Ningbo Menovo Pharmaceutical Co., Ltd.

Ningbo Menovo Pharmaceutical Co., Ltd. has shown remarkable stock performance, significantly outperforming the broader market. Over the past week, the stock has increased by over 40%, with substantial gains year-to-date and over the past year. The company is navigating challenges while demonstrating positive financial trends.

Ningbo Menovo Pharmaceutical Co., Ltd. has shown remarkable short-term stock performance, rising significantly today and over the past week and month, while the broader market has declined. Despite strong quarterly sales and a positive year-to-date performance, the company faces challenges with long-term growth and modest annual sales increases.

Ningbo Menovo Pharmaceutical Co., Ltd. has shown impressive stock performance, gaining 10.02% on March 13, 2026, and achieving a 56.90% return over the past year. The company maintains a manageable debt-to-equity ratio of 0.37 and demonstrates effective receivables management with a turnover ratio of 4.99 times.

Ningbo Menovo Pharmaceutical Co., Ltd. saw a notable increase in stock performance, reaching an intraday high and outperforming the broader market over the past year. The company has a market capitalization of CNY 4,472 million, with solid financial metrics, including a manageable debt-to-equity ratio and a competitive dividend yield.